Percutaneous Fine-Needle 5% Ethanol-Cisplatin Intratumoral Injection Combined with Second-Line Chemotherapy Improves On the Standard of Care in Patients with Platinum-Pretreated Stage IV Non–Small Cell Lung Cancer()

BACKGROUND: Efficacy of second-line chemotherapy in platinum-pretreated non–small cell lung cancer (NSCLC) is poor. This study investigated efficacy of computed tomography–guided percutaneous fine-needle 5% ethanol-cisplatin intratumoral injection (CT-PFNECII) combined with second-line chemotherapy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Niu, Qi, Wang, Wei, Li, Qian, Li, Yong, Ruden, Douglas M., He, Baoming
Format: Artigo
Idioma:Inglês
Publicat: Neoplasia Press 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4101294/
https://ncbi.nlm.nih.gov/pubmed/24726235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2014.02.017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars